Multitarget Molecular Imaging in Metastatic Castration Resistant Adenocarcinoma Prostate Cancer with Therapy Induced Neuroendocrine Differentiation

Neuroendocrine differentiation of prostate cancer (NEDPC) includes de novo presentation and secondary to epigenetic changes, referred as therapy-induced neuroendocrine prostate cancer (t-NEPC). Molecular imaging with prostate-specific membrane antigen (PSMA) and somatostatin analogues positron emiss...

Descripción completa

Detalles Bibliográficos
Autores principales: Vargas Ahumada, Joel, González Rueda, Sofía D., Sinisterra Solís, Fabio A., Pitalúa Cortés, Quetzali, Torres Agredo, Liliana P., Miguel, Jimenez Ríos, Scavuzzo, Anna, Soldevilla-Gallardo, Irma, Álvarez Avitia, Miguel A., Sobrevilla, Nora, García Pérez, Francisco Osvaldo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221809/
https://www.ncbi.nlm.nih.gov/pubmed/35741197
http://dx.doi.org/10.3390/diagnostics12061387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221809/
https://www.ncbi.nlm.nih.gov/pubmed/35741197
http://dx.doi.org/10.3390/diagnostics12061387

Ejemplares similares